Aquila Bioscience has a team of experts from a range of science diciplines, bridging Glycobiology, Immunology, Microbiology, Biochemistry and Analytical Chemistry, providing the highest quality of services and products to its customers.
Research interests lie in the fight against chronic and infectious diseases.

About Us:

Aquila Bioscience is a spin-out company from the National University of Ireland Galway founded by Prof. Lokesh Joshi and Prof. Afshin Samali in August 2012. AquilaBio's emphasis on the innovative application of glycoscience to cell stress in chronic and infectious diseases opens up a new niche opportunity for the company and the region. The co-founders are leaders in their respective fields of academic research and have an extensive network of academic and industrial collaborators worldwide.


AquilaBio News

-Jan 05th 2015: Aquila Bioscience sign contract with the European Defense Agency

-Nov 18th 2014: The Natural Product Biotechnology conference

- Oct 13th 2014: Aquila Bioscience meet with NAPES

-Sep 23rd 2014: Aquila Bioscience has been shortlisted in three categories